Maynard Um
-
-
-
-
-
-
-
Omeros (OMER) Tops Q3 EPS by 11c
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Omeros Corp. (OMER)
-
-
-
-
-
-
-
Omeros (OMER) Provides Update of Ongoing Zaltenibart Phase 3 PNH Clinical Trial Program
-
-
-
-
-
-
-
Increasing unusual call option volume: PRGO MSTZ QBTS OMER RGTI XLI FRSH XLI FRSH ESTC HYLN
-
-
-
-
341,965 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

